Business
Marc Jacobs Acquisition by Toys R Us Parent Unconfirmed
No verified reports confirm Toys R Us parent company acquiring Marc Jacobs as of May 15, 2026.
Search...
1861 results for "top"
Entertainment
Delta Goodrem Leads Australia to Eurovision 2026 Final
Delta Goodrem's flawless performance secured Australia's spot in the Eurovision 2026 grand final.
Sports
Ethiopia vs Morocco: CAN U17 Match Preview
Morocco faces Ethiopia in Group A of the 2026 U17 Africa Cup of Nations on May 16.
Entertainment
Eurovision 2026: UK Entry Struggles in Semi-Finals
The UK's Eurovision 2026 entry faced a setback in the semi-finals, with mixed reviews from critics and fans.
Sports
Arne Slot: No thought of leaving Liverpool despite criticism
Liverpool head coach Arne Slot says he has never considered quitting the club, despite intense fan criticism this season.
Sports
Spain PM backs Yamal in Palestinian flag row
Spain's PM expressed pride in Barcelona's Lamine Yamal after the teen displayed a Palestinian flag during a title parade.
Sports
Min Woo Lee shares PGA Championship lead after round one
Min Woo Lee shot a three-under 69 to share the clubhouse lead at the PGA Championship, while Rory McIlroy criticized his own round.
Sports
Moroccan Teen Ibrahim Rabbaj Impresses Real Madrid, Barcelona
Ibrahim Rabbaj, a 15-year-old Moroccan midfielder, has drawn interest from Real Madrid and Barcelona after standout performances at the U17 Africa Cup of Nation
Technology
Logismed 2026: Connectivity, Data, and Sovereignty
Logismed 2026 in Morocco focused on single window systems, digital platforms, and AI for trade transformation.
Entertainment
Otago Spotted in Netflix's 'East of Eden' Trailer
Netflix's 'East of Eden' trailer features brief shots of Otago, New Zealand, as a filming location.
Sports
Collin Morikawa's Aronimink Practice Raises Concerns
Collin Morikawa's unusual practice session at Aronimink Golf Club has sparked concern among golf analysts.
Health
Celcuity Expands Phase 3 Trial for Breast Cancer Drug
Celcuity's Phase 3 VIKTORIA-2 trial of gedatolisib for HR+/HER2- advanced breast cancer now includes endocrine-sensitive patients.